Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 May 29;14(3):e240347.
doi: 10.1530/ETJ-24-0347. Print 2025 Jun 1.

Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis

Franz Sesti, Tiziana Feola, Pasquale Dolce, Valentina Guarnotta, Alessandro Veresani, Elia Guadagno, Filomena Bottiglieri, Maria Grazia Tarsitano, Andrea M Isidori, Annamaria Colao, Antongiulio Faggiano, Elisa Giannetta; NIKE group
Collaborators
Meta-Analysis

Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis

Franz Sesti et al. Eur Thyroid J. .

Abstract

Background: Early diagnosis of medullary thyroid cancer (MTC) when basal calcitonin (CT) levels are <100 pg/mL remains a clinical challenge. The calcium stimulation test is a unique tool for stimulating CT. However, standardized and sex-specific cutoff values are lacking. Therefore, this study aimed to investigate whether the calcium stimulation test for CT is adequate for diagnosing MTC in both sexes and to identify sex-specific cutoff values.

Methods: This was an individual patient data (IPD) meta-analysis. A literature search was performed using Scopus, PubMed, and Web of Science until September, 2024, to identify articles on the calcium stimulation test for diagnosing MTC.

Results: A total of five studies involving 243 patients (148 females and 95 males) who underwent total thyroidectomy were included in this study. Before surgery, all patients underwent the calcium stimulation test with calcium gluconate (25 mg/kg) for CT assessed by chemiluminescence assay. In females, a global threshold of 162 pg/mL was identified, with a pooled sensitivity of 0.90 (95% confidence interval (95% CI): 0.79-0.97) and specificity of 0.66 (95% CI: 0.56-0.75). The pooled area under the curve (AUC) was 0.87 (95% CI: 0.76-0.97). In males, a global threshold of 562 pg/mL was identified, with a pooled sensitivity of 0.79 (95% CI: 0.60-0.92) and specificity of 0.89 (95% CI: 0.79-0.96). The pooled AUC was 0.94 (95% CI: 0.90-0.99).

Conclusions: The calcium stimulation test for CT for the diagnosis of MTC showed better performance in males than in females, with a suggested cutoff value of 562 pg/mL in males.

Significance statement: The management of indeterminate calcitonin (CT) values is still challenging in the early diagnosis of MTC, lacking general recommendations, which can help clinicians in these cases. This is the first IPD meta-analysis that underscores the sex-based disparity in the diagnostic accuracy of the calcium stimulation test for CT in suspected MTC cases, showing better performance in diagnosing MTC in male versus female patients, with a cutoff value of 562 pg/mL in male subjects. In the context of the limited literature, this paper provides added value for the clinical endocrine practitioner, suggesting the use of the calcium stimulation test in highly selected cases with indeterminate CT values (10-100 pg/mL) with a sex-oriented and personalized approach.

Keywords: calcitonin; calcium stimulation test; medullary thyroid cancer; meta-analysis; sex difference.

PubMed Disclaimer

Conflict of interest statement

AMI has been a consultant for Novartis, Takeda, Recordati, and Sandoz companies and has received unconditional research grants from Shire, IPSEN, and Pfizer. All the other authors have no conflicts of interest.

Figures

Figure 1
Figure 1
Flow diagram for study selection (search until September 2024). RIA, radioimmunoassay; IRMA, immunoradiometric assay
Figure 2
Figure 2
Meta-analysis of AUC in females.
Figure 3
Figure 3
Summary ROC curve for the calcium stimulation test for CT in females. AUC = 0.86; optimal cutoff = 162 pg/mL.
Figure 4
Figure 4
Meta-analysis of AUC in males.
Figure 5
Figure 5
Summary ROC curve for the calcium stimulation test for CT in males. AUC = 0.90; optimal cutoff = 562 pg/mL.
See this image and copyright information in PMC

References

    1. Bartz-Kurycki MA, Oluwo OE & Morris-Wiseman LF. Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis. Ther Adv Endocrinol Metab 2021. 12 20420188211049611. (10.1177/20420188211049611) - DOI - PMC - PubMed
    1. Yan KL, Li S, Tseng CH, et al. . Rising incidence and incidence-based mortality of thyroid cancer in California, 2000–2017. J Clin Endocrinol Metab 2020. 105 1770–1777. (10.1210/clinem/dgaa121) - DOI - PubMed
    1. Elisei R, Alevizaki M, Conte-Devolx B, et al. . 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J 2013. 1 216–231. (10.1159/000346174) - DOI - PMC - PubMed
    1. Redding AH, Levine SN & Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 2000. 10 919–922. (10.1089/thy.2000.10.919) - DOI - PubMed
    1. Wells SA Jr, Asa SL, Dralle H, et al. . Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma. Thyroid 2015. 25 567–610. (10.1089/thy.2014.0335) - DOI - PMC - PubMed

Supplementary concepts